Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease

Movement Disorders

Volumn 30, Issue 7, 2015, Pages 953-959

  Reimão, Sofia ^a,b   Pita Lobo, Patrícia ^a,b,c   Neutel, Dulce ^a,b   Guedes, Leonor Correia ^a,b,c   Coelho, Miguel ^a,b   Rosa, Mário M ^a,b   Azevedo, Pedro ^d   Ferreira, Joana ^d   Abreu, Daisy ^b   Gonçalves, Nilza ^b   Nunes, Rita G ^d   Campos, Jorge ^a   Ferreira, Joaquim J ^a,b,c  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c CNS Campus Neuro ogico enior   (Portugal)

^d UNIVERSITY OF LISBON   (Portugal)

Author keywords

Essential tremor; MRI; Neuromelanin; Parkinson's disease; substantia nigra

Indexed keywords

NEUROMELANIN; MELANIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ESSENTIAL TREMOR; EVALUATION STUDY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOLOGY; PROCEDURES; STANDARDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ESSENTIAL TREMOR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELANINS; MIDDLE AGED; PARKINSON DISEASE; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA;

EID: 84931955392     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26182     Document Type: Article

References (40)

1. Bach JP, Ziegler U, Deuschl G, Dodel R, Doblhammer-Reiter G. Projected numbers of people with movement disorders in the years 2030 and 2050. Mov Disord 2011;26:2286-2290.
2. Louis ED, Thawani SP, Andrews HF. Prevalence of essential tremor in amultiethnic, community-based study in northern Manhattan, New York, N.Y. Neuroepidemiology 2009;32:208-214.
3. Benito-León J, Bermejo-Pareja F, Morales JM, Vega S, Molina JA. Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord 2003;18:389-394.
4. Benito-León J. Essential tremor: one of the most common neurodegenerative diseases? Neuroepidemiology 2011;36:77-78.
5. Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010;25:534-541.
6. Louis ED. Age of onset: can we rely on essential tremor patients to report this? Data from a prospective, longitudinal study. Neuroepidemiology 2013;40:93-98.
7. Hardesty DE, Maraganore DM, Matsumoto JY, Louis ED. Increased risk of head tremor in women with essential tremor: longitudinal data from the Rochester Epidemiology Project. Mov Disord 2004;1:529-533.
8. Pahwa R, Koller WC. Is there a relationship between Parkinson's disease and essential tremor? Clin Neuropharmacol 1993;16:30-35.
9. 123I]-FP-CIT SPECT. Mov Disord 2009;24:500-508.
10. Schrag A, Münchau A, Bhatia KP, et al. Essential tremor: an overdiagnosed condition? J Neurol 2000;245:955-999.
11. Jain S, Lo SE, Lewis ED. Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? Arch Neurol 2006;63:1100-1104.
12. Geraghty JJ, Jankovic J, Zetusky WJ. Association between essential tremor and Parkinson's disease. Ann Neurol 1985;17:329-333.
13. 123I]- FP-CIT SPECT study group. Mov Disord 2000;15:503-510.
14. Pagan FL, Butman JA, Dambrosia JM, Hallett M. Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology 2003;60:1344-1347.
15. Quattrone A, Cerasa A, Messina D, et al. Essential head tremor is associated with cerebellar vermis atrophy: a volumetric and voxel-based morphometry MR imaging study. AJNR Am J Neuroradiol 2008;29:1692-1697.
16. Nicoletti G, Manners D, Novellino F, et al. Diffusion tensor MRI changes in the cerebellar structures of patients with familial essential tremor. Neurology 2010;74:988-994.
17. Louis ED. Essential tremor: evolving clinicopathological concepts in an era of intensive post-mortem enquiry. Lancet Neurol 2010;9:613-622.
18. Stockner H, Sojer M, Seppi K, et al. Midbrain sonography in patients with essential tremor. Mov Disord 2007;22:414-417.
19. Stockner H, Wurster I. Transcranial sonography in essential tremor. Int Rev Neurobiol 2010;90:189-197.
20. Novellino F, Cherubini A, Chriaco C, et al. Brain iron deposition in essential tremor: a quantitative 3-Tesla magnetic resonance imaging study. Mov Disord 2013;28;196-200.
21. Double KL, Gerlach M, Schünemann V, et al. Iron-binding characteristics of neuromelanin of the human substantia nigra. Biochem Pharmacol 2003;66:489-494.
22. Sasaki M, Shibata E, Tohyama K, et al. Neuromelanin magnetic resonance imaging of locus coeruleus and substantia nigra in Parkinson's disease. Neuroreport 2006;17:1215-1218.
23. Sasaki M, Shibata E, Kudo K, Tohyama K. Neuromelanin sensitive MRI. Clin Neuroradiol 2008;18:147-153.
24. Kashihara K, Shinya T, Higaki F. Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease. J Clin Neurosci 2011;18:1093-1096.
25. Blazejewska AL, Schwarz ST, Pitiot A, et al. Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology 2013;81:534-540.
26. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998;13(suppl 3):2-23.
27. Huges AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
28. Nikolaou N, Papamarkos N. Color reduction for complex document images. International Journal of Imaging Systems and Technology 2009;19:14-26.
29. Sun X, Zhang H, Duan H. 3D computerized segmentation of lung volume with computed tomography. Acad Radiol 2006;13:670-677.
30. Reimão S, Pita Lobo P, Neutel D, et al. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients. Eur J Neurol 2014; DOI: 10.1111/ene.1261 [Epub ahead of print].
31. Uitti RJ, Baba Y, Whaley NR, Wszolek ZK, Putzhe JD. Parkinson disease: handedness predicts asymmetry. Neurology 2005;64:1925-1930.
32. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
33. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-2301.
34. Ohtsuka C, Sasaki M, Konno K, et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging. Neurosci Lett 2013;541:93-98.
35. Vlaar AM, van Kroonenburgh MJ, Kessels AG, et al. Meta-analysis of the literature on the diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol 2007;1:27.
36. de la Fuente-Fernandéz R. Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology 2012;78:696-701.
37. Ogisu K, Kudo K, Sasaki M, et al. 3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease. Neuroradiology 2013;55:719-724.
38. Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991;50:743-755.
39. Jellinger KA. Post mortem studies in Parkinson's disease: is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl. 1999;56:1-29.
40. Antonini A, Biundo R. Parkinson's disease: Can dopamine transporter imaging define early PD? Nat Rev Neurol 2014:10:432-433.